Allocati N, Masulli M, Alexeyev MF, Di Ilio C (2013) Escherichia coli in Europe: an overview. Int J Environ Res Public Health 10(12):6235–6254. doi:https://doi.org/10.3390/ijerph10126235
Article PubMed PubMed Central Google Scholar
Beebout CJ, Eberly AR, Werby SH, Reasoner SA, Brannon JR, De S, Fitzgerald MJ, Huggins MM, Clayton DB, Cegelski L, Hadjifrangiskou M (2019) Respiratory heterogeneity shapes biofilm formation and host colonization in uropathogenic Escherichia coli. Bio. https://doi.org/10.1128/mBio.02400-18
Belley A, Huband MD, Fedler KA, Watters AA, Flamm RK, Shapiro S, Knechtle P (2019) Development of broth microdilution MIC and disk diffusion antimicrobial susceptibility test quality control ranges for the combination of cefepime and the novel β-lactamase inhibitor enmetazobactam. J Clin Microbiol 57(8): e0060719
Bessa LJ, Ferreira M, Gameiro P (2018) Evaluation of membrane fluidity of multidrug-resistant isolates of Escherichia coli and Staphylococcus aureus in presence and absence of antibiotics. J Photochem Photobiol B 181:150–156. doi:https://doi.org/10.1016/j.jphotobiol.2018.03.002
Article CAS PubMed Google Scholar
Bruni GN, Kralj JM (2020) Membrane voltage dysregulation driven by metabolic dysfunction underlies bactericidal activity of aminoglycosides. eLife. https://doi.org/10.7554/eLife.58706
Article PubMed PubMed Central Google Scholar
Busscher GF, Rutjes FP, van Delft FL (2005) 2-Deoxystreptamine: central scaffold of aminoglycoside antibiotics. Chem Rev 105(3):775–791. doi:https://doi.org/10.1021/cr0404085
Article CAS PubMed Google Scholar
Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA (2001) Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 104(6):901–912. doi:https://doi.org/10.1016/s0092-8674(01)00286-0
Article CAS PubMed Google Scholar
Campbell M, Cho CY, Ho A, Huang JY, Martin B, Gilbert ES (2020) 4-Ethoxybenzoic acid inhibits Staphylococcus aureus biofilm formation and potentiates biofilm sensitivity to vancomycin. Int J Antimicrob Agents 56(3):106086. doi:https://doi.org/10.1016/j.ijantimicag.2020.106086
Article CAS PubMed Google Scholar
Ciaravino V, Plattner J, Chanda S (2013) An assessment of the genetic toxicology of novel boron-containing therapeutic agents. Environ Mol Mutagen 54(5):338–346. doi:https://doi.org/10.1002/em.21779
Article CAS PubMed Google Scholar
Ciaravino V, Coronado D, Lanphear C, Shaikh I, Ruddock W, Chanda S (2014) Tavaborole, a novel boron-containing small molecule for the topical treatment of onychomycosis, is noncarcinogenic in 2-year carcinogenicity studies. Int J Toxicol 33(5):419–427. doi:https://doi.org/10.1177/1091581814545245
Article CAS PubMed Google Scholar
Coleman SR, Smith ML, Spicer V, Lao Y, Mookherjee N, Hancock REW (2020) Overexpression of the small RNA PA08051 in Pseudomonas aeruginosa modulates the expression of a large set of genes and proteins, resulting in altered motility, cytotoxicity, and tobramycin resistance. mSystems. https://doi.org/10.1128/mSystems.00204-20
Article PubMed PubMed Central Google Scholar
Copp JN, Pletzer D, Brown AS, Van der Heijden J, Miton CM, Edgar RJ, Rich MH, Little RF, Williams EM, Hancock REW, Tokuriki N, Ackerley DF (2020) Mechanistic understanding enables the rational design of salicylanilide combination therapies for gram-negative infections. mBio. https://doi.org/10.1128/mBio.02068-20
Article PubMed PubMed Central Google Scholar
Cvetesic N, Palencia A, Halasz I, Cusack S, Gruic-Sovulj I (2014) The physiological target for LeuRS translational quality control is norvaline. EMBO J 33(15):1639–1653. doi:https://doi.org/10.15252/embj.201488199
Article CAS PubMed PubMed Central Google Scholar
Danchik C, Casadevall A (2020) Role of cell surface hydrophobicity in the pathogenesis of medically-significant fungi. Front Cell Infect Microbiol 10:594973. https://doi.org/10.3389/fcimb.2020.594973
de Breij A, Riool M, Cordfunke RA, Malanovic N, de Boer L, Koning RI, Ravensbergen E, Franken M, van der Heijde T, Boekema BK, Kwakman PHS, Kamp N, El Ghalbzouri A, Lohner K, Zaat SAJ, Drijfhout JW, Nibbering PH (2018) The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aan4044
Denby KJ, Rolfe MD, Crick E, Sanguinetti G, Poole RK, Green J (2015) Adaptation of anaerobic cultures of Escherichia coli K-12 in response to environmental trimethylamine-N-oxide. Environ Microbiol 17(7):2477–2491. doi:https://doi.org/10.1111/1462-2920.12726
Article CAS PubMed PubMed Central Google Scholar
Domenech A, Brochado AR, Sender V, Hentrich K, Henriques-Normark B, Typas A, Veening JW (2020) Proton motive force disruptors block bacterial competence and horizontal gene transfer. Cell Host Microbe 27(4):544-555e3. https://doi.org/10.1016/j.chom.2020.02.002
Article CAS PubMed Google Scholar
Ducret A, Quardokus EM, Brun YV (2016) MicrobeJ, a tool for high throughput bacterial cell detection and quantitative analysis. Nat Microbiol 1(7):16077. doi:https://doi.org/10.1038/nmicrobiol.2016.77
Article CAS PubMed PubMed Central Google Scholar
Ejim L, Farha MA, Falconer SB, Wildenhain J, Coombes BK, Tyers M, Brown ED, Wright GD (2011) Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol 7(6):348–350. doi:https://doi.org/10.1038/nchembio.559
Article CAS PubMed Google Scholar
Foxman B (2010) The epidemiology of urinary tract infection. Nat Rev Urol 7(12):653–660. https://doi.org/10.1038/nrurol.2010.190
Gaibani P, Lombardo D, Lewis RE, Mercuri M, Bonora S, Landini MP, Ambretti S (2014) In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates. J Antimicrob Chemother 69(7):1856–1865. doi:https://doi.org/10.1093/jac/dku065
Article CAS PubMed Google Scholar
Goodlet KJ, Benhalima FZ, Nailor MD (2019) A systematic review of single-dose aminoglycoside therapy for urinary tract infection: is it time to resurrect an old strategy? Antimicrob Agents Chemother. https://doi.org/10.1128/aac.02165-18
Gunther G, Malacrida L, Jameson DM, Gratton E, Sánchez SA (2021) LAURDAN since Weber: the quest for visualizing membrane heterogeneity. Acc Chem Res 54(4):976–987. https://doi.org/10.1021/acs.accounts.0c00687
Article CAS PubMed PubMed Central Google Scholar
Hamamoto H, Urai M, Ishii K, Yasukawa J, Paudel A, Murai M, Kaji T, Kuranaga T, Hamase K, Katsu T, Su J, Adachi T, Uchida R, Tomoda H, Yamada M, Souma M, Kurihara H, Inoue M, Sekimizu K (2015) Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. Nat Chem Biol 11(2):127–133. doi:https://doi.org/10.1038/nchembio.1710
Article CAS PubMed Google Scholar
Hankittichai P, Lou HJ, Wikan N, Smith DR, Potikanond S, Nimlamool W (2020) Oxyresveratrol inhibits IL-1β-induced inflammation via suppressing AKT and ERK1/2 activation in human microglia, HMC3. Int J Mol Sci. https://doi.org/10.3390/ijms21176054
Article PubMed PubMed Central Google Scholar
Hansen E, Karslake J, Woods RJ, Read AF, Wood KB (2020) Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations. PLoS Biol 18(5): e3000713. https://doi.org/10.1371/journal.pbio.3000713
Article CAS PubMed PubMed Central Google Scholar
Hoffman LR, D’Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436(7054):1171–1175. doi:https://doi.org/10.1038/nature03912
Article CAS PubMed Google Scholar
Idowu T, Ammeter D, Rossong H, Zhanel GG, Schweizer F (2019) Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria. J Med Chem 62(20):9103–9115. https://doi.org/10.1021/acs.jmedchem.9b00876
Article CAS PubMed Google Scholar
Igler C, Rolff J, Regoes R (2021) Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens. eLife. https://doi.org/10.7554/eLife.64116
Article PubMed PubMed Central Google Scholar
Jia T, Liu B, Mu H, Qian C, Wang L, Li L, Lu G, Zhu W, Guo X, Yang B, Huang D, Feng L, Liu B (2021) A novel small RNA promotes motility and virulence of enterohemorrhagic Escherichia coli O157:H7 in response to ammonium. mBio. https://doi.org/10.1128/mBio.03605-20
Article PubMed PubMed Central Google Scholar
Kulik M, Mori T, Sugita Y, Trylska J (2018) Molecular mechanisms for dynamic regulation of N1 riboswitch by aminoglycosides. Nucleic Acids Res 46(19):9960–9970. doi:https://doi.org/10.1093/nar/gky833
Article CAS PubMed PubMed Central Google Scholar
Leviton IM, Fraimow HS, Carrasco N, Dougherty TJ, Miller MH (1995) Tobramycin uptake in Escherichia coli membrane vesicles. Antimicrob Agents Chemother 39(2):467–475. doi:https://doi.org/10.1128/aac.39.2.467
Article CAS PubMed PubMed Central Google Scholar
Liu Y, Jia Y, Yang K, Li R, Xiao X, Zhu K, Wang Z (2020) Metformin restores tetracyclines susceptibility against multidrug resistant bacteria. Adv Sci (Weinheim Baden-Wurttemberg Germany) 7(12):1902227. https://doi.org/10.1002/advs.201902227
Luther A, Urfer M, Zahn M, Müller M, Wang SY, Mondal M, Vitale A, Hartmann JB, Sharpe T, Monte FL, Kocherla H, Cline E, Pessi G, Rath P, Modaresi SM, Chiquet P, Stiegeler S, Verbree C, Remus T, Schmitt M, Kolopp C, Westwood MA, Desjonquères N, Brabet E, Hell S, LePoupon K, Vermeulen A, Jaisson R, Rithié V, Upert G, Lederer A, Zbinden P, Wach A, Moehle K, Zerbe K, Locher HH, Bernardini F, Dale GE, Eberl L, Wollscheid B, Hiller S, Robinson JA, Obrecht D (2019) Chimeric peptidomimetic antibiotics against Gram-negative bacteria. Nature 576(7787):452–458. doi:https://doi.org/10.1038/s41586-019-1665-6
留言 (0)